Northwest Biotherapeutics's quarterly market cap
declined
from Sep. 2023 ($1,041.68 Mil) to Dec. 2023 ($824.00 Mil) and
declined
from Dec. 2023 ($824.00 Mil) to Mar. 2024 ($0.00 Mil).
Northwest Biotherapeutics's annual market cap
increased
from Dec. 2021 ($663.88 Mil) to Dec. 2022 ($838.16 Mil) but then
declined
from Dec. 2022 ($838.16 Mil) to Dec. 2023 ($824.00 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Northwest Biotherapeutics's Enterprise Value for Today is $644.02 Mil.
Northwest Biotherapeutics Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Northwest Biotherapeutics's Market Cap
For the Biotechnology subindustry, Northwest Biotherapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Northwest Biotherapeutics's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Northwest Biotherapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Northwest Biotherapeutics's Market Cap falls into.
Northwest Biotherapeutics Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Northwest Biotherapeutics (OTCPK:NWBO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Northwest Biotherapeutics Market Cap Related Terms
Thank you for viewing the detailed overview of Northwest Biotherapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Northwest Biotherapeutics (Northwest Biotherapeutics) Business Description
Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a broad range of solid-tumor cancers. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. The product portfolio includes product candidates such as DCVax-L, for patients with brain cancer; DCVax-Direct, direct injection into all types of inoperable solid tumor cancers, and DCVax for late-stage ovarian cancer. DCVax-Prostate, for late-stage prostate cancer, has received clearance from the U.S. Food and Drug Administration.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NWBO has been successfully added to your 